Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2013, Article ID 129813, 4 pages
http://dx.doi.org/10.1155/2013/129813
Case Report

Renal Medullary Cancer in a Patient with Sickle Cell Trait

1Division of Pulmonary and Critical Care Medicine, Montefiore Hospital, Albert Einstein College of Medicine, Yeshiva University, New York, NY, USA
2Department of Internal Medicine, University of Iowa Hospital, University of Iowa, Iowa, IA, USA
3Department of Pathology, Montefiore Hospital, Albert Einstein College of Medicine, Yeshiva University, New York, NY, USA
4Department of Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Harvard University, 50 Fruit Street, Boston, MA, USA

Received 21 June 2013; Accepted 31 July 2013

Academic Editors: J. M. Buchanich and F. A. Mauri

Copyright © 2013 Narendrakumar Alappan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. Davis Jr., F. K. Mostofi, and I. A. Sesterhenn, “Renal medullary carcinoma: the seventh sickle cell nephropathy,” American Journal of Surgical Pathology, vol. 19, no. 1, pp. 1–11, 1995. View at Google Scholar · View at Scopus
  2. K. Sathyamoorthy, A. Teo, and M. Atallah, “Renal medullary carcinoma in a patient with sickle-cell disease,” Nature Clinical Practice Urology, vol. 3, no. 5, pp. 279–283, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Molitierno Jr. and C. C. Carson III, “Urologic manifestations of hematologic disease: sickle cell, leukemia, and thromboembolic disease,” Urologic Clinics of North America, vol. 30, no. 1, pp. 49–61, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. A. Hakimi, P. T. Koi, P. M. Milhoua et al., “Renal medullary carcinoma: the Bronx experience,” Urology, vol. 70, no. 5, pp. 878–882, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. P. Raman, R. H. Hruban, and E. K. Fishman, “Beyond renal cell carcinoma: rare and unusual renal masses,” Abdominal Imaging, vol. 37, no. 5, pp. 873–884, 2012. View at Google Scholar
  6. A. Ashley-Koch, Q. Yang, and R. S. Olney, “Sickle hemoglobin (Hb S) allele and sickle cell disease: a HuGE review,” American Journal of Epidemiology, vol. 151, no. 9, pp. 839–845, 2000. View at Google Scholar · View at Scopus
  7. G. Tsaras, A. Owusu-Ansah, F. O. Boateng, and Y. Amoateng-Adjepong, “Complications associated with sickle cell trait: a brief narrative review,” American Journal of Medicine, vol. 122, no. 6, pp. 507–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. G. Motulsky, “Frequency of sickling disorders in U.S. blacks,” The New England Journal of Medicine, vol. 288, no. 1, pp. 31–33, 1973. View at Google Scholar · View at Scopus
  9. A. F. Fleming, “The presentation, management and prevention of crisis in sickle cell disease in Africa,” Blood Reviews, vol. 3, no. 1, pp. 18–28, 1989. View at Google Scholar · View at Scopus
  10. M. A. Swartz, J. Karth, D. T. Schneider, R. Rodriguez, J. B. Beckwith, and E. J. Perlman, “Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications,” Urology, vol. 60, no. 6, pp. 1083–1089, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Simpson, X. He, M. Pins et al., “Renal medullary carcinoma and ABL gene amplification,” Journal of Urology, vol. 173, no. 6, pp. 1883–1888, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. X. Cheng, M. Tretiakova, C. Gong, S. Mandal, T. Krausz, and J. B. Taxy, “Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior,” Modern Pathology, vol. 21, no. 6, pp. 647–652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. J. Motzer, J. Bacik, T. Mariani, P. Russo, M. Mazumdar, and V. Reuter, “Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology,” Journal of Clinical Oncology, vol. 20, no. 9, pp. 2376–2381, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Mariño-Enríquez, W.-B. Ou, C. B. Weldon, J. A. Fletcher, and A. R. Pérez-Atayde, “ALK rearrangement in sickle cell trait-associated renal medullary carcinoma,” Genes Chromosomes & Cancer, vol. 50, no. 3, pp. 146–153, 2011. View at Publisher · View at Google Scholar · View at Scopus